Does IXEKIZUMAB Cause Injection site warmth? 480 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 480 reports of Injection site warmth have been filed in association with IXEKIZUMAB (TALTZ). This represents 1.4% of all adverse event reports for IXEKIZUMAB.
480
Reports of Injection site warmth with IXEKIZUMAB
1.4%
of all IXEKIZUMAB reports
0
Deaths
5
Hospitalizations
How Dangerous Is Injection site warmth From IXEKIZUMAB?
Of the 480 reports, 5 (1.0%) required hospitalization.
Is Injection site warmth Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IXEKIZUMAB. However, 480 reports have been filed with the FAERS database.
What Other Side Effects Does IXEKIZUMAB Cause?
Injection site pain (3,799)
Psoriasis (2,818)
Drug ineffective (2,759)
Injection site erythema (2,144)
Injection site reaction (1,701)
Injection site swelling (1,615)
Incorrect dose administered (1,032)
Covid-19 (861)
Product dose omission issue (832)
Therapy interrupted (796)
What Other Drugs Cause Injection site warmth?
ETANERCEPT (4,011)
ADALIMUMAB (1,275)
DUPILUMAB (889)
ENBREL (544)
GLATIRAMER (372)
HYDROXYPROGESTERONE CAPROATE (287)
HUMIRA (261)
NALTREXONE (231)
TIRZEPATIDE (213)
GALCANEZUMAB-GNLM (197)
Which IXEKIZUMAB Alternatives Have Lower Injection site warmth Risk?
IXEKIZUMAB vs JAKAFI
IXEKIZUMAB vs JANUMET
IXEKIZUMAB vs JANUVIA
IXEKIZUMAB vs JETREA
IXEKIZUMAB vs JUXTAPID